2014.1-8 FDA approved drug

2014.1-8 FDA approved drug

No.	Drug Name	Active Ingredient	Date	What It’s Used For
23.	Orbactiv	oritavancin	8/6/2014	To treat adults with skin  infections * X1 w" ], q5 P3 N  `  Press Release
22.	Jardiance	empagliflozin	8/1/2104	To improve gylcemic control  in adults with type 2 diabetes 2 G( c/ g' o3 }+ v: A" u  Press Release
21.	Striverdi  Respimat	olodaterol	7/31/2014	To treat chronic obstructive  pulmonary disease " \! i8 c( j( k  Press Release
20. ( p! z8 W! f* F* |5 j4 d/ F( E) l	Zydelig	idelalisib	7/23/2014	To treat patients with trhee  types of blood cancers   Press Release
19.	Kerydin    ; N! v5 U3 j( N, W0 j$ a& t. f# P	tavaborole	7/7/2014	For the topical treatment of  onychomycosis of the toenails   (No Press Release)
18.	Beleodaq	belinostat	7/3/2014	To treat patients with  peripheral T-cell lymphoma (PTCL) ) D( A* Z% ?! f$ g, k  Press Release
17.	Sivextro (tablet)Sivextro  (injection)	tedizolid phosphate	6/20/2014	To treat adults with skin  infections 3 A3 x% Z( a5 C9 J0 b  Press Release
16.	Jublia # {2 r. X- A/ l   1 I' Q0 h" m( Y	efinaconazole	6/6/2014	Treat mild to moderate  onychomycosis (fungal infection)    No Press Release
15.	Dalvance    * u, \' S1 O3 x3 o8 M	dalbavancin	5/23/2014	To treat adults with skin  infections / g% x% H" [9 Q' q9 F4 b" v  n  Press Release
14.	Entyvio    ; P1 x* w3 S4 r: t- `/ ^	vedolizumab	5/20/2014	To treat adult patients with  moderate to severe ulcerative colitis and adult patients with moderate to  severe Crohn‘s disease 8 ~( o$ Y' U) c  Press Release
13.	Zontivity    6 o, L) d- V+ f. H9 P/ w8 J	vorapaxar	5/8/2014	To reduce the risk of heart  attacks and stroke in high-risk patients   Press Release
12.	Zykadia	ceritinib	4/29/2014	To treat patients with a  certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC) 1 |9 A/ n  _* C' F* ?: A: D  Press Release
11.	Sylvant	siltuximab	4/23/2014	To treat patients with multicentric  Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the  lymph nodes)   Press Release
10.	Cyramza	ramucirumab	4/21/2014	To treat patients with  advanced stomach cancer or gastroesophageal junction adenocarcinoma # K( n( _$ n7 Q9 X  Press Release
9.	Tanzeum	albiglutide	4/15/2014	To improve glycemic control,  along with diet and exercise, in adults with type 2 diabetes * `' y" v! p2 H+ m, g6 e/ U  Press Release
8.	Otezla	apremilast	3/21/2014	To treat adults with active  psoriatic arthritis (PsA) 4 I& a. k: J+ X1 M. b. F; F8 A" D3 U, T' X  Press Release
7.	Impavido	miltefosine	3/19/2014	To treat a tropical disease  called leishmaniasis 6 w* k$ v& r7 s  Press Release
6.	Neuraceq	florbetaben F 18 injection	3/19/2014	For Positron  EmissionTomography (PET) imaging of the brain
5.	Myalept	metreleptin for injection	2/24/2014	To treat the complications  of leptin deficiency   Press Release
4.	Northera	droxidopa	2/18/2014	To treat neurogenic  orthostatic hypotension (NOH)   Press Release
3.	Vimizim	elosulfase alfa	2/14/2014	Treatment for Mucopolysaccharidosis Type IVA  (Morquio A syndrome)   Press Release
2.	Hetlioz	tasimelteon	1/31/2014	To treat non-24- hour sleep-wake disorder (“non-24”)  in totally blind individuals. Non-24 is a chronic circadian rhythm (body  clock) disorder in the blind that causes problems with the timing of sleep.Press Release
1.	Farxiga	dapaglifozin	1/8/2014	To improve glycemic control,  along with diet and exercise, in adults with type 2 diabetes   Press Release

6 h5 J2 T0 y" t, w/ E7 f

! r! L2 l6 k  X6 C/ D

感谢楼主分享，楼主好强大